China Resources Pharmaceutical Group Ltd. (HK:3320) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
China Resources Pharmaceutical Group Ltd. has increased its stake in Dong-E-E-Jiao by 1% through its subsidiary, CR Pharmaceutical Investment. The group now controls approximately 33.58% of Dong-E-E-Jiao and plans to boost its shareholding further by up to 1.2% over the next six months. This move is aimed at reinforcing investor confidence and supporting the stable growth of the company.
For further insights into HK:3320 stock, check out TipRanks’ Stock Analysis page.